Diffuse alveolar haemorrhage (DAH) is characterised by diffuse pulmonary opacities, respiratory failure, a falling haemoglobin level along with presence of hemosiderin-laden macrophages on bronchoalveolar lavage (BAL). Finding the underlying aetiology of DAH can be challenging but of importance as the treatment and prognosis are largely determined by it. We report a case of DAH with underlying cocaine abuse, a rare cause for the same.
Discussion
Cocaine is abused by around 18.2 million people, most of which are young active males [1] . In India, a small proportion of Indians are estimated to be current users of cocaine (males: 0.18%; females: 0.01%). The proportion of people using cocaine in harmful and dependent pattern is further less (0.03%) [2] . Cocaine is a naturally occurring alkaloid available in four forms: hydrochloride salt, freebase, bazuco and crack. Crack cocaine is the most potent and addictive form with smoking being the preferred method of use [3] . Smoking of cocaine exposes the lung directly to the volatilized drug as well as to the other combustion products of the smoked mixture, thereby increasing the risk of adverse pulmonary effects.
Pulmo nary complications of cocaine toxicity include acute eosinophilic pneumonia, pneumothorax, pneumomediastinum, pulmonary hypertension and rarely DAH [4] . Due to differences in the pattern of consumption and natural history of cocaine-induced lung diseases, the incidence and exact mechanism is unknown. In our case, numerous other possible causes of DAH were considered and excluded, leaving cocaine-induced DAH as the most likely cause of the patient's presentation. The dramatic improvement without any immunosuppressants argued against a vasculitic process, besides, the negative autoimmune screening tests for the same. In view of spontaneous and rapid resolution, corticosteroids were not given in our patient similar to a recently reported case [5] .
In view of rapid resolution of reported cases with supportive care questions the routine use of pulse steroids in DAH, especially in the absence of any autoimmune features. The need of the hour is to collect all these scattered cases of drug induced DAH and attempt to conclude consensus treatment guideline for the same. Cocaine inhalation may result in alveolar haemorrhage by vasoconstriction of the pulmonary circulation resulting in anoxic cell damage or by a direct toxic effect. Cocaine acts by stimulating adrenergic receptors through increased levels of norepinephrine, and, to a lesser extent, epinephrine producing a sympathomimetic, local anaesthetic, and vasoconstrictive effect [6] . Cocaine producing DAH is often diagnosed as an occult haemorrhage unearthed in autopsy. Evidence of acute or chronic alveolar haemorrhage was found in 71% of autopsies of patients in whom toxicologic tests for cocaine, conducted by a medical examiner, were positive. In an autopsy series of 20 patients whose deaths were related to cocaine intoxication, 85% of cases demonstrated pulmonary haemorrhage. Spontaneous resolution of cocaine induced DAH necessitates the focus on supportive management and appropriate ventilatory strategies as literature also reports complications due to barotrauma like pneumothorax [5, 7] . The reported cases of cocaine and DAH over the last 15 years are summarized in Table 2 . The cases summarized clearly show that not all the patients were treated with immunosuppressants. However, the survival and treatment given may be related to the severity of disease at presentation. The cases in which the patients survived had spontaneous resolution of DAH without immunosuppression [6, [8] [9] [10] [11] [12] [13] [14] . The mortality was, however, reported in few cases, with ventilator-associated pneumonia and catheter-associated urinary tract infection being common. This further emphasizes the importance of making the correct etiological diagnosis, else patients with DAH given immunosuppressants for suspected underlying vasculitis can develop opportunistic infec- tions, thereby, increasing morbidity and mortality [7] . Therapy for DAH consists of treating both the autoimmune destruction of the alveolar capillary membrane and the underlying condition. Corticosteroids remain the gold standard for most patients, espe-cially if associated with systemic or pulmonary vasculitis or Goodpasture's syndrome [15] , but may not be advocated as a blanket therapy for all cases. A search for the underlying aetiology determines the treatment and outcome of the patient. 
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